🧬 Tirzepatide 50mg – High‑Purity Research Peptide Product Overview Tirzepatide is a synthetic dual‑agonist research peptide used in studies involving GIP and GLP‑1 receptor signalling. Its dual‑pathway profile makes it a key molecule of interest in metabolic regulation, appetite signalling, glucose utilisation, and energy‑balance research models. Our Tirzepatide 50mg is supplied as a high‑purity lyophilised peptide, suitable for laboratory, academic, and in‑vitro research applications. Key Research Areas Dual‑agonist metabolic signalling Energy expenditure & balance models Appetite regulation pathways Glucose metabolism research Body‑weight regulation mechanisms Peptide‑based metabolic modulation Product Specifications Peptide: Tirzepatide Strength: 50mg Form: Lyophilised powder Purity: ≥ 98% (HPLC tested) Appearance: White powder Storage: Refrigerated; avoid heat exposure Packaging: Sterile, sealed research vial Use: For laboratory research only Research Insights Dual‑Agonist Activity Tirzepatide is studied for its simultaneous interaction with GIP and GLP‑1 receptors, offering a unique dual‑pathway profile in metabolic research. Metabolic Regulation Research models explore how Tirzepatide influences energy expenditure, appetite signalling, and glucose utilisation. Body‑Weight Mechanisms Tirzepatide is used in experimental setups examining weight‑modulation pathways and dual‑agonist metabolic responses. Why Choose CRC Research? UK‑based research peptide supplier High‑purity peptides with verified testing Fast dispatch and secure packaging Trusted by academic and laboratory researchers Important Notice This product is strictly for laboratory research use only. Not for human consumption, medical use, or diagnostic use. Frequently Asked Questions Is Tirzepatide legal to purchase in the UK Yes — Tirzepatide can be purchased for research purposes only. Does Tirzepatide require cold storage Yes. It should be kept refrigerated to maintain stability. What type of research uses Tirzepatide Tirzepatide is commonly used in studies involving dual‑agonist metabolic pathways, appetite regulation, and energy‑balance research.